Rainbow trout (Oncorhynchus mykiss) physiological response to microplastics and enrofloxacin: Novel pathways to investigate microplastic synergistic effects on pharmaceuticals

Abstract

Enrofloxacin (ENR) is a broad-spectrum antibiotic widely used due to its efficacy against pathogens. Microplastics (MPs) may bind to ENR and reduce its efficiency, whereas there would be an increase in its toxicity, bioavailability, and bio-accumulation rates. Therefore, the hypothesis is that the interaction between MPs and ENR can alter their toxicity and bioavailability. The subjective of this study is to examine the toxicity of various concentrations of ENR (0, 1.35, and 2.7 ml Kg−1 diet) and MPs (0, 1000, and 2000 mg Kg−1 diet) alone and in combination for 21 days. The rainbow trout (Oncorhynchus mykiss) is an economic aquaculture species used as an experimental model in ecotoxicology studies. Blood biochemical analytes indicated that ENR and MPs combination led to increasing enzymatic activity of each biomarker, except for gamma-glutamyl-transferase (GGT). Alterations related to triglycerides, cholesterol, glucose, urea, creatinine, total protein, and albumin blood contents were observed. An elevation in the levels of superoxide dismutase (SOD), malondialdehyde (MDA), and glucose 6-phosphate dehydrogenase (G6PDH) was found in the liver. In contrast, catalase (CAT) and glutathione peroxidase (GPx) levels decreased. Furthermore, a decline was observed in the cellular total antioxidant (ANT) levels. These findings suggested that ENR and MPs could affect fish health both independently and together. Consequently, the study determined that when both ENR and MPs were present in high concentrations, the toxicity of ENR was amplified, providing further evidence of the synergistic impact of MPs on ENR toxicity.